(Q44087175)

29 November 2017

1 reference

title

Bias as a threat to the validity of cancer molecular-marker research (English)

1 reference

29 November 2017

1 reference

David F Ransohoff

1

1 reference

PubMed ID

15685197

29 November 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

29 November 2017

Nature Reviews Cancer

1 reference

29 November 2017

5

1 reference

29 November 2017

142-149

1 reference

29 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1550

29 November 2017

0 references

cites work

Trends in microarray analysis

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

Detection of cancer-specific markers amid massive mass spectral data

21 January 2018

1 reference

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

21 January 2018

1 reference

A data review and re-assessment of ovarian cancer serum proteomic profiling

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

Selection bias in gene extraction on the basis of microarray gene-expression data

21 January 2018

1 reference

A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples

21 January 2018

1 reference

Towards sound epistemological foundations of statistical methods for high-dimensional biology

21 January 2018

1 reference

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

Bias in analytic research

21 January 2018

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

The discrepancy between observational studies and randomized trials of menopausal hormone therapy: did expectations shape experience?

21 January 2018

1 reference

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

21 January 2018

1 reference

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

21 January 2018

1 reference

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

21 January 2018

1 reference

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

Gene-Expression Signatures in Breast Cancer

21 January 2018

1 reference

Running before we can walk?

21 January 2018

1 reference

Cancer. Developing molecular biomarkers for cancer

21 January 2018

1 reference

A test before its time? FDA stalls distribution process of proteomic test

31 March 2020

1 reference

Debate rages over proteomic patterns.

31 March 2020

1 reference

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

31 March 2020

1 reference

High-resolution serum proteomic patterns for ovarian cancer detection.

31 March 2020

1 reference

DNA microarrays in breast cancer: the promise of personalised medicine

31 March 2020

1 reference

Getting the noise out of gene arrays

31 March 2020

1 reference

Rules of evidence for cancer molecular-marker discovery and validation

31 March 2020

1 reference

Discovery-based research and fishing

31 March 2020

1 reference

Epidemiology faces its limits.

31 March 2020

1 reference

Evaluating discovery-based research: when biologic reasoning cannot work

31 March 2020

1 reference

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia

31 March 2020

1 reference

The state of outcome research: are we on target?

31 March 2020

1 reference

Problems of comorbidity in mortality after prostatectomy

31 March 2020

1 reference

The risks of risk adjustment

31 March 2020

1 reference

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

31 March 2020

1 reference

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

31 March 2020

1 reference

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1550

1 reference

29 November 2017

1 reference

PubMed ID

15685197